Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

A series of sulfonamides was prepared by reaction of sulfanilamide with aryl/alkyl isocyanates. The ureido-substituted benzenesulfonamides showed a very interesting profile for the inhibition of several carbonic anhydrases (CAs, EC 4.2.1.1) such as the human hCA II and three β-CAs from pathogenic fungal or bacterial species. The Candida albicans enzyme was inhibited with potencies in the range of 3.4-3970 nM, whereas the Mycobacterium tuberculosis enzymes Rv1284 and Rv3273 were inhibited with K(i)s in the range of 4.8-6500 nM and of 6.4-6850 nM, respectively. The structure-activity relationship for this class of inhibitors is rather complex, but the main features associated with effective inhibition of both α- and β-CAs investigated here have been delineated. The nature of the moiety substituting the second ureido nitrogen is the determining factor in controlling the inhibitory power, probably due to the flexibility of the ureido linker and the possibility of this moiety to orientate in different subpockets of the active site cavities of these enzymes.

Knowledge Graph

Similar Paper

Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides
Bioorganic & Medicinal Chemistry Letters 2011.0
Carbonic anhydrase inhibitors. The β-carbonic anhydrases from the fungal pathogens Cryptococcus neoformans and Candida albicans are strongly inhibited by substituted-phenyl-1H-indole-5-sulfonamides
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis and human/bacterial carbonic anhydrase inhibition with a series of sulfonamides incorporating phthalimido moieties
Bioorganic & Medicinal Chemistry 2017.0
Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 β-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides
Bioorganic & Medicinal Chemistry Letters 2009.0
Molecular Cloning, Characterization, and Inhibition Studies of the Rv1284 β-Carbonic Anhydrase from Mycobacterium tuberculosis with Sulfonamides and a Sulfamate
Journal of Medicinal Chemistry 2009.0
Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates
Bioorganic & Medicinal Chemistry 2011.0
Inhibition studies of new ureido-substituted sulfonamides incorporating a GABA moiety against human carbonic anhydrase isoforms I–XIV
Bioorganic & Medicinal Chemistry 2014.0
Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII
European Journal of Medicinal Chemistry 2016.0
Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Carbonic anhydrase inhibitors: Inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides
Bioorganic & Medicinal Chemistry Letters 2013.0